News

News

Finally Kristina was able to get tested

After having lost her mom and maternal grandmother to breast cancer, Kristina wondered about her hereditary risk. Kristina got tested with GeneMate.

News

iCellate Medical expands its accredited lab

iCellate has recently finalized the expansion of its lab for the accredited service GeneMate®. GeneMate® is a service that is used to analyze an…

News

iCellate Medical secures 20 MSEK in new funding

iCellate Medical has closed a successful round of financing, raising 20 MSEK from a combination of existing and new investors.

News

iCellate launches collaboration with football player Olivia Schough

Cancer diagnostics company iCellate Medical AB announces collaboration with football star Olivia Schough. Olivia shares her story of hereditary cancer…

News

Project ELEVATE initiates clinical trial for development of novel cancer diagnostics

February 10, 2022. Elthera AG, iCellate Medical AB, Targos Molecular Pathology GmbH and Prof. Dr. Susanne Sebens at the Institute of Experimental…

News

iCellate Expands Headquarters

News

GeneMate® now a part of global rare disease database and resource Orphanet

Increased visibility of hereditary cancer risk can lead to increased opportunities for cancer prevention and early detection

News

Job Opening: Clinical Molecular Geneticist

Come join us!

News

iCellate’s lab receives ISO 15189 certification by Swedac

iCellate is the only Swedish company that holds an ISO 15189 certification within cancer diagnostics.

News

Elthera-led consortium initiates development of novel cancer diagnostics and therapeutics

News

iCellate has been selected to participate in Novartis' Techcare program

News

Study presented at KICancer - StratCan

News

iCellate enters partnership with RCC Stockholm-Gotland

News

iCellate Medical closes 15 million SEK second round of funding

News

iCellate Medical receives orders for clinical CTC services from major institutions and adds valuable sequencing competence to the company